Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Saum Ghodoussipour
Affiliation
Rutgers Cancer Institute of New Jersey
ORCID
Career Start Year
2016
Papers
76
H Index
12
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37640582
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)].
Eur Urol Focus
2024
37953186
Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer.
Urol Oncol
2024
36244470
Characteristics of Medical Schools in the United States Associated With Successful Match into Urology Residency Programs: Analysis of the 2016-2021 Urology Resident Cohort.
Urology
2023
37509395
The Role of Salvage Radical Prostatectomy in Patients with Radiation-Resistant Prostate Cancer.
Cancers (Basel)
2023
37017928
Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?
Curr Urol Rep
2023
37246134
Annual trends of cystectomy complications: A contemporary analysis of the NSQIP database.
Urol Oncol
2023
37270358
A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non-muscle-invasive Bladder Cancer.
Eur Urol Focus
2023
37093319
Impact of smoking on urologic cancers: a snapshot of current evidence.
World J Urol
2023
36519902
Wound Complication Rates after Inguinal Lymph Node Dissection: Contemporary Analysis of the NSQIP Database.
J Am Coll Surg
2023
36868881
Factors associated with clinical trial participation for patients with renal cell carcinoma.
Urol Oncol
2023
36710211
Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review.
Eur Urol Focus
2023
36938621
Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma.
Technol Cancer Res Treat
2023
34694164
Quantifying Publication Rates and Time to Publication for American Urological Association Podium Presentations.
J Urol
2022
35844831
Updates on enhanced recovery after surgery for radical cystectomy.
Ther Adv Urol
2022
35510081
Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy.
Prostate Int
2022
35599109
Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patients.
Urol Oncol
2022
35528467
Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis.
Am J Clin Exp Urol
2022
35691439
The Impact of Venous Thromboembolism on Mortality and Morbidity During Nephrectomy for Renal Mass.
Urology
2022
35752822
Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations.
BMC Urol
2022
36428737
Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review.
Cancers (Basel)
2022
35906798
Single-Port Robotic Radical Prostatectomy: Short-Term Outcomes and Learning Curve.
J Endourol
2022
36204358
The use of blue-light cystoscopy in the detection and surveillance of nonmuscle invasive bladder cancer.
Curr Urol
2022
36230536
Population-Based Assessment of Determining Predictors for Discharge Disposition in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Cancers (Basel)
2022
35892271
Editorial Comment.
J Urol
2022
35947809
Editorial Comment.
J Urol
2022
36051251
Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments.
Arch Pharmacol Ther
2022
35044045
Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder.
BJU Int
2022
35007620
Robotic Repair of Ureteroenteric Stricture Following Radical Cystectomy: A Multi-Institutional Experience.
Urology
2022
34978466
Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer.
J Urol
2022
35144865
Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysis.
Urol Oncol
2022
35105510
Factors Associated With Palliative Intervention Utilization for Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
2022
32979377
Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation.
Urology
2021
33882992
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples.
Clin Epigenetics
2021
33625919
Reply by Authors.
J Urol
2021
34765447
Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341-342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer.
Asian J Urol
2021
34713977
Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second-line antiandrogen therapy era.
Cancer Med
2021
34298032
Patient Reported Sexual Function Outcomes in Male Patients Following Open Radical Cystoprostatectomy and Urinary Diversion.
Urology
2021
34263255
Immune Checkpoint Inhibitors in the Management of Urothelial Carcinoma.
J Cancer Immunol (Wilmington)
2021
34058241
Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life?
Urology
2021
34089170
Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol.
Int Urol Nephrol
2021
33999800
Enhanced recovery after cystectomy in patients with preoperative narcotic use.
Can Urol Assoc J
2021
33035137
Timing, Patterns and Predictors of 90-Day Readmission Rate after Robotic Radical Cystectomy.
J Urol
2021
33223368
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
Urol Oncol
2021
33356480
An Objective Assessment of Performance during Robotic Partial Nephrectomy: Validation and Correlation of Automated Performance Metrics with Intraoperative Outcomes.
J Urol
2021
33348465
Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients.
BJU Int
2021
32900621
Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response.
Urol Oncol
2021
31346762
Using objective robotic automated performance metrics and task-evoked pupillary response to distinguish surgeon expertise.
World J Urol
2020
31728671
Comparison of clinical outcomes and automated performance metrics in robot-assisted radical prostatectomy with and without trainee involvement.
World J Urol
2020
32055488
Surgical strategies for postchemotherapy testis cancer.
Transl Androl Urol
2020
32648804
Reply by Authors.
J Urol
2020
1 - 50 of 76
Column Actions
Search
Recommended Authors
Giovanni Motterle
Mayo Clinic
Career Start Year
2017
Number of shared co-authors
0
Riccardo Campi
Careggi University Hospital
Career Start Year
2014
Number of shared co-authors
0
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year
2013
Number of shared co-authors
0
David C Johnson
University of North Carolina School of Medicine
Career Start Year
2012
Number of shared co-authors
0
Devin N Patel
university of california san diego School of Medicine
Career Start Year
2011
Number of shared co-authors
0
Izak Faiena
Columbia University Medical Center
Career Start Year
2010
Number of shared co-authors
0
Aaron A Laviana
Dell Medical School, The University of Texas at Austin
Career Start Year
2010
Number of shared co-authors
0
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Joseph Brito
Yale School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year
2008
Number of shared co-authors
0
Michael A Liss
University of Texas Health San Antonio
Career Start Year
2008
Number of shared co-authors
0
Jonathan L Wright
University of Washington Medical Center
Career Start Year
2005
Number of shared co-authors
1
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year
2005
Number of shared co-authors
1
Amirali Salmasi
University of California San Diego
Career Start Year
2005
Number of shared co-authors
0
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year
2004
Number of shared co-authors
0
Edward Rowe
Bristol Urological Institute, Southmead Hospital
Career Start Year
2004
Number of shared co-authors
0
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Career Start Year
2002
Number of shared co-authors
0
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Career Start Year
2001
Number of shared co-authors
1
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
2001
Number of shared co-authors
1
John L Gore
University of Washington School of Medicine
Career Start Year
2001
Number of shared co-authors
1
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1999
Number of shared co-authors
1
Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year
1999
Number of shared co-authors
1
Jim C Hu
Weill Cornell Medical Center
Career Start Year
1998
Number of shared co-authors
0
Todd M Morgan
University of Michigan ann arbor
Career Start Year
1997
Number of shared co-authors
2
Omer Acar
University of Illinois at Chicago
Career Start Year
1996
Number of shared co-authors
0
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
1996
Number of shared co-authors
1
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year
1994
Number of shared co-authors
1
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
1993
Number of shared co-authors
1
Damien Bolton
University of Melbourne
Career Start Year
1988
Number of shared co-authors
0
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Phillip M Pierorazio
Co-authored papers
2
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers
1
Inbar Fried
University of North Carolina School of Medicine
Co-authored papers
1
Andrew L Beam
Harvard T. H. Chan School of Public Health
Co-authored papers
1
Yap Ching Chew
Zymo Research Corporation
Co-authored papers
1
Isaac S Kohane
Harvard Medical School
Co-authored papers
1
Surena F Matin
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
Helen C Hood
Boston Children's Hospital, Harvard Medical School
Co-authored papers
1
Jessica J Lee
Center for Drug Evaluation and Research
Co-authored papers
1
Richard J Grand
Boston Children's Hospital, Harvard Medical School
Co-authored papers
1
Athos Bousvaros
Boston Children's Hospital
Co-authored papers
1
Yaqun Wang
Co-authored papers
1
Nathan Palmer
Harvard Medical School
Co-authored papers
1
Vladimir I Valtchinov
Center for Evidence-Based Imaging, Brigham and Women's Hospital
Co-authored papers
1
Louis M Kunkel
Boston Children's Hospital and Harvard Medical School
Co-authored papers
1
Seok Soo Byun
Seoul National University Bundang Hospital
Co-authored papers
1
Jocelyn A Silvester
Beth Israel Deaconess Medical Center
Co-authored papers
1
Fedik Rahimov
AbbVie Inc.
Co-authored papers
1
Sek Won Kong
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers
1
1 - 19